abstract |
The present invention relates to methods of screening for compounds that modulate the expression of the cannabinoid CBl and CB2 receptors, and methods for modulating receptor activity. The invention also relates to the use of CB 1 and CB2 receptors and/or binding partners for identification of pharmacologically active agents, and their use for enhancing wound healing and treating wound healing disorders. |